Eagle Health Investments Lp Top Holdings and 13F Report (2024) About Eagle Health Investments LpInvestment ActivityEagle Health Investments Lp has $528.00 million in total holdings as of September 30, 2024.Eagle Health Investments Lp owns shares of 25 different stocks, but just 12 companies or ETFs make up 80% of its holdings.Approximately 9.62% of the portfolio was purchased this quarter.About 29.22% of the portfolio was sold this quarter.This quarter, Eagle Health Investments Lp has purchased 26 new stocks and bought additional shares in 4 stocks.Eagle Health Investments Lp sold shares of 8 stocks and completely divested from 2 stocks this quarter.Largest Holdings Natera $54,755,312Illumina $50,514,835argenx $40,650,579ICON Public $37,577,275Insmed $37,500,100 Largest New Holdings this Quarter Neurocrine Biosciences $14,817,292 Holding Largest Purchases this Quarter Neurocrine Biosciences 128,600 shares (about $14.82M)BioMarin Pharmaceutical 187,412 shares (about $13.17M)DexCom 175,774 shares (about $11.78M)Illumina 68,600 shares (about $8.95M)Ultragenyx Pharmaceutical 37,200 shares (about $2.07M) Largest Sales this Quarter United Therapeutics 113,400 shares (about $40.64M)UnitedHealth Group 36,200 shares (about $21.17M)TransMedics Group 114,800 shares (about $18.02M)Intuitive Surgical 20,900 shares (about $10.27M)argenx 13,900 shares (about $7.53M) Sector Allocation Over TimeMap of 500 Largest Holdings ofEagle Health Investments Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNTRANatera$54,755,312$5,433,460 ▼-9.0%431,31410.4%MedicalILMNIllumina$50,514,835$8,946,126 ▲21.5%387,3549.6%MedicalARGXargenx$40,650,579$7,534,912 ▼-15.6%74,9907.7%MedicalICLRICON Public$37,577,275$5,401,428 ▼-12.6%130,7907.1%MedicalINSMInsmed$37,500,1000.0%513,7007.1%MedicalEXASExact Sciences$37,070,9040.0%544,2007.0%MedicalRAREUltragenyx Pharmaceutical$31,202,435$2,066,460 ▲7.1%561,7005.9%MedicalDXCMDexCom$30,268,024$11,783,889 ▲63.8%451,4925.7%MedicalUNHUnitedHealth Group$29,643,276$21,165,416 ▼-41.7%50,7005.6%MedicalBMRNBioMarin Pharmaceutical$29,466,411$13,173,189 ▲80.9%419,2125.6%MedicalINSPInspire Medical Systems$28,830,0630.0%136,6035.5%MedicalALNYAlnylam Pharmaceuticals$20,972,6880.0%76,2564.0%MedicalUTHRUnited Therapeutics$19,386,377$40,636,891 ▼-67.7%54,0993.7%MedicalPRCTPROCEPT BioRobotics$18,675,091$1,922,880 ▼-9.3%233,0893.5%MedicalNBIXNeurocrine Biosciences$14,817,292$14,817,292 ▲New Holding128,6002.8%MedicalAGIOAgios Pharmaceuticals$14,698,7770.0%330,8302.8%MedicalCRSPCRISPR Therapeutics$9,255,0600.0%197,0001.8%MedicalFDMT4D Molecular Therapeutics$5,004,0680.0%462,9110.9%MedicalLNTHLantheus$4,741,2000.0%43,2000.9%MedicalISRGIntuitive Surgical$3,630,485$10,267,542 ▼-73.9%7,3900.7%MedicalVKTXViking Therapeutics$2,848,9500.0%45,0000.5%MedicalTMDXTransMedics Group$2,835,577$18,023,600 ▼-86.4%18,0610.5%MedicalHOWLWerewolf Therapeutics$1,484,0000.0%700,0000.3%MedicalIMCRImmunocore$1,441,3190.0%46,3000.3%MedicalGRAIL INC$730,9860.0%53,1240.1%COMIQVIQVIA$0$25,773,479 ▼-100.0%00.0%MedicalGHGuardant Health$0$18,105,132 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.